PB

Pravin Bhimrao Kamble

Active Director Designated Partner DIN 10605430
DIN 10605430 First appointment Apr 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Pravin Bhimrao Kamble

Data last updated:

Pravin Bhimrao Kamble is a Designated Partner at Medsource Clinical Research Llp (since 2024).

DIN 10605430
Primary Designation Designated Partner
First Appointment 26 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 Apr 20242024Active

Board colleagues of Pravin Bhimrao Kamble

Directorship timeline

Open interactive timeline →
Medsource Clinical Research Llp
Premium access

Shareholding and investment profile for Pravin Bhimrao Kamble

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pravin Bhimrao Kamble

Pravin Bhimrao Kamble currently holds 1 directorship: Medsource Clinical Research Llp (Designated Partner, since 26 Apr 2024).

Pravin Bhimrao Kamble was first appointed on 26 Apr 2024 as Designated Partner at Medsource Clinical Research Llp.

The current boards of Pravin Bhimrao Kamble's companies include Anil Mhalappa Bhalerao (Medsource Clinical Research Llp), Dnyaneshwar Ganpat Kumbhar (Medsource Clinical Research Llp), Gaurav Suhas Patil (Medsource Clinical Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available